CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 71 enrolled
Drug / intervention
Belladonna and Opium +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03332056
NCT03332056Phase 4Completed
CompareCT.gov

The Use of Belladonna and Opium (B&O) Suppository in the Treatment of Postoperative Stent Pain: A Randomized, Double-Blinded Control Study

University of Washington·interventional·Posted Nov 6, 2017·Updated Jun 18, 2023

In Brief

A Phase 4 clinical trial evaluating Belladonna and Opium and Placebo suppository for Nephrolithiasis. Completed, enrolled 71 participants.

Detailed Summary

The purpose of this study is to determine if preemptive B\&O suppository placement will decrease post-operative pain in patients undergoing ureteral stent placement.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNephrolithiasis
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 6, 2017
Enrollment StartAug 1, 2013
Primary CompletionOct 1, 2014
Study CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.7 years ago

Interventions

Belladonna and Opiumdrug

Placebo suppositoryother